SpectraCure AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SpectraCure AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7547
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SpectraCure AB (SpectraCure) is a provider of cancer treatment solutions that offers medical device systems containing laser light sources and photoreactive drugs. The company develops and therapy system, commercializes photodynamic with IDOSE for tumors. It provides IDOSE platform which allows tomographic mapping and controls the interstitial PDT treatments, used for accurate dosimetry of internal tumors and to avoid damage to healthy tissue. SpectraCure offers IDOSE which can also perform real-time adjustments to the dose plan covering the different parts of the target tissue. The company’s IDOSE offers treatments through 3D image-based treatment planning using advanced dose-planning tools. It also provides multicentre clinical trials for recurrent prostate cancer. SpectraCure is headquartered in Lund, Sweden.

SpectraCure AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SpectraCure AB, Medical Devices Deals, 2012 to YTD 2018 9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SpectraCure AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
SpectraCure Partners with Princess Margaret Hospital 11
SpectraCure Enters into Agreement with Larix 12
Equity Offering 13
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants 13
SpectraCure AB – Key Competitors 14
SpectraCure AB – Key Employees 15
SpectraCure AB – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Feb 23, 2018: New patient treatment in the clinical phase 1 study 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SpectraCure AB, Pharmaceuticals & Healthcare, Key Facts 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SpectraCure AB, Deals By Therapy Area, 2012 to YTD 2018 8
SpectraCure AB, Medical Devices Deals, 2012 to YTD 2018 9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SpectraCure Partners with Princess Margaret Hospital 11
SpectraCure Enters into Agreement with Larix 12
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants 13
SpectraCure AB, Key Competitors 14
SpectraCure AB, Key Employees 15

List of Figures
SpectraCure AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SpectraCure AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SpectraCure AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SpectraCure AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Micron Technology Inc:企業のM&A・事業提携・投資動向
    Micron Technology Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Micron Technology Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Ocular Therapeutix Inc (OCUL):製薬・医療:M&Aディール及び事業提携情報
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • Franklin Resources Inc:企業の戦略・SWOT・財務分析
    Franklin Resources Inc - Strategy, SWOT and Corporate Finance Report Summary Franklin Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dundee Corporation:企業のM&A・事業提携・投資動向
    Dundee Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dundee Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Laird PLC (LRD):企業の財務・戦略的SWOT分析
    Laird PLC (LRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Isagen SA ESP:企業の発電所・SWOT分析2018
    Isagen SA ESP - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Blue Cross and Blue Shield of Florida Inc:企業の戦略的SWOT分析
    Blue Cross and Blue Shield of Florida Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Bank Zachodni WBK SA:戦略・SWOT・企業財務分析
    Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report Summary Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PharMerica Corporation:企業の戦略・SWOT・財務情報
    PharMerica Corporation - Strategy, SWOT and Corporate Finance Report Summary PharMerica Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CTI Clinical Trial and Consulting Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CTI Clinical Trial and Consulting Services Inc (CTI) is a contract research company (CRO) that offers clinical trial and consulting services. The company offers services such as project management, clinical data management, biostatistics, clinical monitoring, safety and pharmacovigilance and …
  • B. Braun Melsungen AG:戦略・SWOT・企業財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Viridian Group Investments Ltd:電力:M&Aディール及び事業提携情報
    Summary Viridian Group Investments Limited (Viridian), a subsidiary of Viridian Group Holdings Limited, is an independent energy company. Through subsidiaries, it generates and supplies electricity in Northern Ireland and the Republic of Ireland (RoI). It supplies natural gas to business customers i …
  • Graphic Packaging Holding Company
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • AC Immune SA (ACIU):企業の財務・戦略的SWOT分析
    AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Imerys SA:企業のM&A・事業提携・投資動向
    Imerys SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imerys SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Targa Resources Corp.:企業の戦略・SWOT・財務情報
    Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Damodar Valley Corp:企業の戦略的SWOT分析
    Damodar Valley Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Filtration Group Corporation:企業の戦略的SWOT分析
    Filtration Group Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆